James B. Koprich, MA, PhD, is chief scientific officer at Atuka Inc.; a scientific associate at Toronto Western Hospital, University Health Network; and visiting professor of neurology at Huashan Hospital, Fudan University. His research in Parkinson’s disease has largely focused on development and characterization of disease models and on pre-clinical evaluation of novel therapeutics for disease modification and reduction of dyskinesia. Dr. Koprich has conducted a number of studies contributing to the understanding of disease pathogenesis.